What Xelay Acumen does

Xelay Acumen is a privately-held healthcare strategy and management consulting firm founded in 2012 by Alex Yang, MD, MBA (former McKinsey consultant), headquartered in San Mateo, California with an analytics office in Taipei, Taiwan. The firm operates across six divisions: Consulting, Analytics and Information, Medical and Scientific, Xelay Capital (investment affiliate), Sports Management, and Xelay Foundation. It serves biotechnology, pharmaceutical, and healthcare provider clients with strategy consulting, medical affairs, publication planning, KOL engagement, FDA advisory committee preparation, and a growing portfolio of analytical tools including Health Economics Outcomes Modeling, a MACE Risk Calculator, a Dosing Rubric Calculator, and clinical trial recruitment analytics.

The firm's revenue model is built on professional services engagements ranging from one week to multi-year contracts with enterprise clients in life sciences, supplemented by a fee-based investment advisory stream via Xelay Capital (33% average annual returns since 2007 in 15 of 18 years) and adjacent sports management services for professional athletes. The 60+ person team is unusually science-heavy, with 20 advanced-degree holders (MDs, PhDs, PharmDs) contributing to 500+ publications completed. GTM is enterprise field sales through referrals and direct executive relationships, with the firm positioning itself as a "long-term integrated partner" rather than a transactional consultancy, evidenced by multi-year program engagements that have produced documented outcomes including $75M financing rounds and a $2.7B acquisition for a client within two years.

Underlying the consulting practice is an increasingly productized analytics stack: proprietary dosing conversion models, real-world EMR-derived risk calculators, and an AI-powered autograding and automation system (launched September 2025) trained on internal rubrics. The business makes money primarily through time-and-materials consulting engagements and project-based analytical services at undisclosed premium rates consistent with healthcare-specialized strategy firms, with no public pricing disclosed.

Name

Xelay Acumen

Legal name

Xelay Acumen Group, Inc.

Website

https://xelayacumen.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

101–250 employees

Short description

Xelay Acumen is a private healthcare strategy and management consulting firm founded in 2012 that serves biotechnology, pharmaceutical, and healthcare provider clients through strategy, medical affairs, analytics, and publication services, supplemented by Xelay Capital investment advisory, sports management, and a non-profit foundation.

Ownership category

akta.pro rank

Product category

Healthcare Management Consulting

NAICS

Management Consulting Services (54161), Other Scientific and Technical Consulting Services (541690)

SIC

Services-Management Consulting Services (8742), Services-Engineering, Accounting, Research, Management (8700)

akta.pro primary industry

Data, Analytics & AI Consulting (BPAHAEAF)

Keywords

• Healthcare strategy consulting
• Medical affairs consulting
• Biopharma management consulting
• Clinical data analytics
• Medical communications services

Headquarters

HQ city

San Mateo

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Management Consulting Services: Strategy and management consulting engagements serving biotechnology, pharmaceutical, and healthcare provider clients. Engagements focus on high-value adding work for critically important issues including organizing scientific information, improving communication of data, cultivating influencing relationships, and building scientific narratives.
2. Capital Investment Advisory: Xelay Capital advisory investment affiliate achieving capital appreciation through investing primarily in publicly traded equity securities and exchange-traded funds. The fund has achieved average returns of 33% per year since inception in late 2007.
3. Sports Management Services: Dedicated division providing athlete representation, financial and business management, brand development, revenue growth, strategic partnerships, and live event operations for professional athletes.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Xelay Acumen is a healthcare strategy and management consulting firm delivering strategic problem solving, rigorous analyses, and clear communications to biotechnology, pharmaceutical, and healthcare provider clients. The firm operates six divisions covering consulting, analytics, medical/scientific communications, capital investment, sports management, and a non-profit foundation, with engagements ranging from one week to multiple years. Beyond consulting services, the firm develops proprietary analytical tools (e.g., MACE Risk Calculator, Dosing Rubric Calculator, Health Economics Outcomes Modeling) and an AI-powered autograding system used in client engagements.

Product overview

Xelay Acumen is a healthcare strategy and management consulting firm operating across six divisions: Consulting Group, Analytics and Information Group, Medical and Scientific Group, Xelay Capital, Sports Management Division, and Xelay Foundation. The core consulting services integrate strategic problem solving, advanced data analytics, and clear communications to address critical issues for biotechnology, pharmaceutical, and healthcare provider clients. The Analytics division delivers proprietary analytical tools including the MACE Risk Calculator, Dosing Rubric Calculator, and AI-powered autograding systems, alongside health economics outcomes modeling and clinical trial recruitment analytics. The Medical and Scientific Group provides publication strategy, planning, and medical writing services with over 500 publications completed. Xelay Capital manages an investment fund with 33% average annual returns since 2007. Sports Management Division supports professional athletes with business management, branding, and career planning services.

Differentiator

Problem solved

Functional benefit

Brands

• Xelay Capital: The advisory investment affiliate of Xelay Acumen focused on achieving capital appreciation through investing primarily in publicly traded equity securities and exchange-traded funds.

Products and services

• Strategy and Management Consulting Services Core strategy and management consulting services for biotechnology, pharmaceutical, and healthcare provider clients. Delivers strategic problem solving, rigorous analyses, and clear communications to address critical client issues. Engagements range from 1 week to several years.
• Analytics and Information Services Advanced analytical and modeling services including sophisticated big data analytics, patient clinical outcomes analysis, medical and commercial drug comparisons, pricing optimization, and market research insights using questionnaire sciences and survey design.
• Medical and Scientific Communications Services Medical communications and scientific services including publication strategy, planning and medical writing. Team of 20+ individuals with MDs, PhDs, and PharmDs holding over 200 years of collective experience and 500+ publications completed.
• Sports Management Services Dedicated division supporting professional athletes in building sustainable careers through athlete representation, contract negotiation, sponsorship procurement, wealth management, branding, public relations, business strategy, and career planning.
• FDA Advisory Committee Advocacy Services Strategic grass roots advocacy campaign development to prepare patient, provider, and professional society participants for FDA Advisory Committee oral public hearings.
• Publication Planning and Medical Writing Services Strategic scientific publication planning, medical writing, and congress presentation services including manuscript development for prestigious journals like NEJM and JAMA, and conference presentations including late-breaking trials.

Quantifiable outcome

• 500+ clinical data slides produced in 72 hours
• +7 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability17 records

Feature3 records

Scale indicators10 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• ZS Associates: Large professional services firm specializing in pharmaceuticals and healthcare with deep expertise in data, analytics, and strategy consulting. Highly comparable in serving biopharma clients with analytical rigor and commercial strategy work.
• L.E.K. Consulting: Global strategy consulting firm with one of the largest dedicated life sciences practices. Comparable in serving biotech and pharma clients on medical affairs, commercialization, and corporate strategy engagements.
• Trinity Partners (now part of Carlyle): Specialized strategy consulting firm focused on life sciences, providing commercial strategy, medical affairs, and analytics services to biopharma clients. Comparable boutique model and healthcare-only focus.
• Charles River Associates: Global consulting firm with a dedicated Life Sciences practice serving pharmaceutical and biotech clients on commercial strategy, pricing, and market access. Comparable in serving biopharma with specialized expertise.
• ClearView Healthcare Partners: Boutique strategy consulting firm exclusively serving pharmaceutical, biotechnology, and medical device clients with similar specialized medical affairs and commercial strategy expertise. Comparable in size, healthcare-only focus, and integrated long-term partnership model.

Broad incumbents

• Bain & Company: Global management consulting firm with a Healthcare practice serving pharmaceutical and biotech clients. Comparable as a broad incumbent competitor for the same set of enterprise healthcare clients.
• McKinsey & Company: The largest global management consulting firm with a substantial Pharmaceutical & Medical Products practice. Comparable as the firm where Xelay's founder previously worked and as a primary competitor for top biopharma engagements.
• IQVIA: Large healthcare-focused services and data platform providing consulting, analytics, and technology to biopharma clients. Comparable in serving pharma clients with combined data analytics and strategy expertise at significantly larger scale.
• Boston Consulting Group: Global management consulting firm with a dedicated Healthcare practice serving pharmaceutical, biotech, and provider clients. Comparable as a major competitor for enterprise biopharma strategy work.
• Syneos Health Consulting: Biopharmaceutical services organization with a consulting practice addressing commercial strategy, medical affairs, and market access for pharma and biotech clients. Comparable in addressing the same functional needs across biopharma.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@xelayacumen5249

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Xelay Acumen